Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New company LipimetiX created to focus on lipid-lowering treatments

April 30, 2010

Diamyd Medical continues phase III trials of Diamyd in diabetes

April 29, 2010

BioCryst reports on phase IIa trial of BCX-4208 in patients with gout

April 29, 2010

Phase II data presented on pasireotide in Cushing's disease and acromegaly

April 29, 2010

Living Cell Technologies receives grant from JDRF for phase II DiabeCell trial

April 28, 2010

Santaris advances SPC-5001 into development to lower cholesterol

April 28, 2010

No endocrine safety concerns noted in phase II trials of ulipristal acetate for uterine fibroids

April 28, 2010

Greater HbA1c reductions with LY-2189265 in Hispanic patients with type 2 diabetes

April 28, 2010

GlaxoSmithKline presents new calcium receptor antagonists

April 27, 2010

GSK discloses new calcium-sensing receptor antagonists

April 26, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...